KDM6B and neuroblastoma: JMJD3 inhibition has also been shown to cause the accumulation of H3K27me3, disturbing the interaction of transcription factors and resulting in the downregulation of the CDK4/6-pRB-E2F pathway and of MYCN in neuroblastoma [13].